Virginia Oncology Associates

Elizabeth City, NC

Sorting 2 by

Accepting patients

Teclistamab or Talquetamab

Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Learn more
  • Bispecific Antibody
  • BCMA
  • Phase 2
  • Has results

Accepting patients

MajesTEC-4

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation - MajesTEC-4
Learn more
  • Bispecific T Cell Engager (BiTE)
  • Bispecific Antibody
  • BCMA
  • Phase 3